BioAtla (BCAB) Capital Expenditures (2020 - 2023)
BioAtla's (BCAB) quarterly Capital Expenditures came in at $8000.0 in Q4 2023, down 97.0% year-on-year from $267000.0 in Q4 2022, and down 68.0% quarter-over-quarter from $25000.0 in Q3 2023.
BioAtla (BCAB) Capital Expenditures (2020 - 2023) Analysis & Trends
BioAtla's Capital Expenditures history runs 4 years deep, the most recent figure standing at $8000.0 for Q4 2023.
- On a quarterly basis, Capital Expenditures fell 97.0% year-over-year to $8000.0 in Q4 2023; TTM through Sep 2024 was $8000.0, a 97.76% decrease from a year earlier, with the FY2023 full-year figure at $98000.0, down 63.43% from the prior year.
- Capital Expenditures retreated to $8000.0 in Q4 2023 per BCAB's latest filing, from $25000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $793000.0 in Q3 2021 and bottomed at -$834000.0 in Q4 2021.
- The 4-year median for Capital Expenditures is $24000.0 (2022), against an average of $59812.5.
- Biggest YoY gain for Capital Expenditures was 627.52% in 2021; the steepest drop was 565.22% in 2021.
- Year by year, Capital Expenditures stood at $395000.0 in 2020, then sank by 311.14% to -$834000.0 in 2021, then soared by 132.01% to $267000.0 in 2022, then sank by 97.0% to $8000.0 in 2023.
- Per Business Quant, the three latest BCAB Capital Expenditures figures stand at $8000.0 (Q4 2023), $25000.0 (Q3 2023), and $15000.0 (Q2 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | BioAtla | 5.74 Mn | 5.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 8,000.00 |
| Dec 31, 2023 | 8,000.00 |
| Sep 30, 2023 | 25,000.00 |
| Sep 30, 2023 | 25,000.00 |
| Jun 30, 2023 | 15,000.00 |
| Jun 30, 2023 | 15,000.00 |
| Mar 31, 2023 | 50,000.00 |
| Mar 31, 2023 | 50,000.00 |
| Dec 31, 2022 | 267,000.00 |
| Dec 31, 2022 | 267,000.00 |
| Sep 30, 2022 | -32,000.00 |
| Sep 30, 2022 | -32,000.00 |
| Jun 30, 2022 | 10,000.00 |
| Jun 30, 2022 | 10,000.00 |
| Mar 31, 2022 | 23,000.00 |
| Mar 31, 2022 | 23,000.00 |
| Dec 31, 2021 | -834,000.00 |
| Dec 31, 2021 | -834,000.00 |
| Sep 30, 2021 | 793,000.00 |
| Sep 30, 2021 | 793,000.00 |